BTC ETH SOL BNB XRP Fear & Greed
AltcoinGordon
Price

ADA Price: MACD Reading Splits Blockchain.News, Tokenist

Blockchain.News (2026-08-24) and The Tokenist disagree on whether ADA's MACD signals exhausted momentum or bullish momentum, and on where the 200-day moving average sits.

Original AltcoinGordon illustration for: ADA Price: MACD Reading Splits Blockchain.News, Tokenist
Original illustration, drawn for this story by AltcoinGordon.

Blockchain.News (2026-08-24) and The Tokenist disagree on whether ADA's MACD signals exhausted momentum or bullish momentum, and on where the 200-day moving average sits.

What all sources agree on

  • ADA is trading near $0.22.
  • RSI is reported in the mid-to-high 60s.

Where the reports disagree

1MACD momentum direction

The MACD histogram has zeroed out — buyers exhausted themselves getting price up to this level, and the follow-through simply hasn't arrived. Momentum has gone completely flat.

Blockchain.News (2026-08-24)

FXStreet's daily reading puts the Relative Strength Index (RSI) in the mid-60s, with the Moving Average Convergence Divergence (MACD) positive and above its signal line, momentum that favors buyers, though not without the risk of near-term exhaustion after a 29% weekly advance.

The Tokenist

What would settle it: A shared, timestamped MACD chart from a single data provider (e.g., FXStreet or TradingView) for ADA/USD at the same interval and moment.

2Location of the 200-day moving average

At $0.22, Cardano is sitting precisely on its 200-day simple moving average, the one level every institutional algo on the street watches.

Blockchain.News (2026-08-24)

with the 200-day EMA forming the outer boundary near $0.249.

The Tokenist

What would settle it: Recomputing ADA's 200-day SMA and 200-day EMA independently from exchange price history for the same date.

What to make of it

Treat ADA's roughly $0.22 price and mid-to-high-60s RSI as broadly agreed; do not treat the MACD signal or the 200-day average level as settled, since the two reports describe them in opposite or inconsistent terms.

Treat ADA's roughly $0.22 price and mid-to-high-60s RSI as broadly agreed; do not treat the MACD signal or the 200-day average level as settled, since the two reports describe them in opposite or inconsistent terms.